Evidence mapPaperPMID 39935012Full record

ArticleJMIR formative research2025

Assessing Dynamic Cognitive Function in the Daily Lives of Youths With and Without Type 1 Diabetes: Usability Study.

Mary Katherine Ray, Jorie Fleming, Andrew Aschenbrenner, Jason Hassenstab, Brooke Redwine, Carissa Burns, Ana Maria Arbelaez, Mary Ellen Vajravelu, Tamara Hershey

Abstract read
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary Katherine RayDepartment of Psychiatry, Washington University in St. Louis, 660 S. Euclid Avenue, St. Louis, MO, 63110, United States, 1 3142738322.ORCID 0000-0002-8586-032X
Jorie FlemingDepartment of Psychiatry, Washington University in St. Louis, 660 S. Euclid Avenue, St. Louis, MO, 63110, United States, 1 3142738322.ORCID 0000-0002-8366-7825
Andrew AschenbrennerDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, United States.ORCID 0000-0002-4317-7282
Jason HassenstabDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, United States.ORCID 0000-0002-7802-3371
Brooke RedwineDepartment of Psychiatry, Washington University in St. Louis, 660 S. Euclid Avenue, St. Louis, MO, 63110, United States, 1 3142738322.ORCID 0009-0006-7970-7042
Carissa BurnsDepartment of Psychiatry, Washington University in St. Louis, 660 S. Euclid Avenue, St. Louis, MO, 63110, United States, 1 3142738322.ORCID 0009-0000-4560-7875
Ana Maria ArbelaezDepartment of Pediatrics, Washington University in St. Louis, St. Louis, MO, United States.ORCID 0000-0001-6977-9786
Mary Ellen VajraveluDivision of Pediatric Endocrinology, Diabetes, and Metabolism, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.ORCID 0000-0002-5839-7923
Tamara HersheyDepartment of Psychiatry, Washington University in St. Louis, 660 S. Euclid Avenue, St. Louis, MO, 63110, United States, 1 3142738322.ORCID 0000-0001-7549-0698

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · 2022 to 2025
$5.6M
BIOMEDICAL RESEARCH TRAINING IN DRUG ABUSET32DA007261 · WASHINGTON UNIVERSITY · 1991 to 2025
$2.2M
Washington University Institute of Clinical and Translational Sciences (KL2)KL2TR002346 · WASHINGTON UNIVERSITY · 2025 to 2025
$1.4M
The Washington University Center for Diabetes Translation ResearchP30DK092950 · WASHINGTON UNIVERSITY · 2025 to 2025
$850k
WUSTL Transdisciplinary Pre- and Postdoctoral Training Program in Obesity and Cardiovascular DiseaseT32HL130357 · WASHINGTON UNIVERSITY · 2025 to 2025
$275k
Impact of Glucose Variability on Dynamic Cognitive Function in Youth with Type 1 DiabetesK01DK131339 · WASHINGTON UNIVERSITY · 2025 to 2025
$120k
Within-person dynamics of cognition and personality in healthy aging and Alzheimer's disease.K01AG071847 · WASHINGTON UNIVERSITY · 2025 to 2025
$95k
NCATS NIH HHS KL2 TR002346NHLBI NIH HHS T32 HL130357NIA NIH HHS K01 AG071847NIDA NIH HHS T32 DA007261NIDDK NIH HHS K01 DK131339NIDDK NIH HHS K23 DK125719NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK092950
6 · The paper itself

Abstract

Background: Studies have shown a relationship between worse glycemic control and lower cognitive scores in youths with type 1 diabetes (T1D). However, most studies assess long-term glucose control (eg, years-decades) and cognition at a single time point. Understanding this relationship at a higher temporal resolution (eg, minutes-hours) and in naturalistic settings has potential clinical implications. Newer technology (eg, continuous glucose monitoring [CGM] and ecological momentary assessment) provides a unique opportunity to explore the glucose dynamics that influence dynamic cognition; that is, cognitive functions that fluctuate short-term and are influenced by environmental factors. Objective: Before we can assess this relationship, we need to determine the feasibility of measuring cognition in youths in daily life and determine the plausibility of obtaining glucose variation with CGM to be integrated with real-time cognition measures. This study's purpose was to assess the acceptability of measuring dynamic cognition using a smartphone app and adherence to cognitive testing in daily life in youths with and without T1D. Further, we assessed CGM-derived glucose measures at temporally related timeframes to cognitive testing in naturalistic settings. Methods: Data were obtained from 3 studies including one in-laboratory study and 2 remote studies. For all studies, youths were asked to complete cognitive tests on the Ambulatory Research in Cognition (ARC) smartphone app that measured processing speed, associative memory, and working memory. For the in-laboratory study, youths completed testing 4 times during 1 session. For the remote studies, youths were asked to complete cognitive tests 5 times per day for either 10 or 14 consecutive days in daily life. Youths were asked to rate their impressions of the app. Youths with T1D wore a CGM. Results: 74 youths (n=53 control; n=21 T1D) aged 4-16 years participated. Youths generally reported liking or understanding the ARC app tasks in a laboratory and remote setting. Youths had high testing adherence in daily life (2350/3080 to 721/900, 76.3%-80.2%) and none dropped out. The percentage of measurements within each glycemic range taken immediately before the app's cognitive testing was 3% (28/942) low glucose, 51% (484/942) euglycemia, 23% (221/942) high glucose, and 22% (210/942) very high glucose. In the 2-hour window before each cognitive task, mean glucose was 182.5 (SD 76.2) mg/dL, SD in glucose was 27.1 mg/dL (SD 18.7), and the mean maximum difference between the highest and lowest glucose was 85.5 (SD 53.7) mg/dL. Conclusions: The results suggest that using the ARC smartphone app to assess dynamic cognitive functions in youths with and without T1D is feasible. Further, we showed CGM-derived glycemic variability at temporally associated timeframes of dynamic cognitive assessments. The next steps include using ecological momentary assessment in a fully powered study to determine the relationship between short-term glycemic control and cognition in youths with T1D.

Indexed as

CognitionDiabetes Mellitus, Type 1AdolescentBlood GlucoseBlood Glucose Self-MonitoringChildEcological Momentary AssessmentFeasibility StudiesFemaleHumansMaleMobile ApplicationsBlood GlucoseacceptabilityambulatoryappapplicationassessmentCGMcognitive testcontinuous glucose monitoringdaily livesdiabetesecological momentary assessmentEMAenvironmental factorfeasibility studyglycemic controlmobile phonephonepilot studysmartphonetype 1 diabetesyoungyouth

Identifiers

PMID39935012
PMCPMC11835789

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.